Infertility Drugs Market by 2029 Opportunity, Challenges & Entry Strategy

Infertility disorders can seriously impact the health of an individual at both physical and mental levels.



Infertility disorders can seriously impact the health of an individual at both physical and mental levels. In the recent past, the growing occurrence of lifestyle disorders, stress, and increasing alcohol and tobacco consumption has boosted the infertility rate across the globe. According to a World Health Organisation (WHO) report, Against this backdrop, the global infertility drugs market is expected to mature in the coming years. infertility is a global health issue that affects millions of people, about 48 million couples and 186 million individuals to be precise. The growing environmental damage caused by pollution and contamination of soil and water also contributes to decreasing fertility rates en masse. In such circumstances, many healthcare organisations, pharmaceutical manufacturers, and government bodies are taking serious cognizance of the issue. The sales and demand for fertility medications and infertility treatments such as in-vitro fertilisation procedures have skyrocketed.


For More Industry Insight Read :

Increasing Incidence of Lifestyle Disorders to Create Demand Surge in Infertility Drugs Market


Research has discovered time and again that several lifestyle disorders can adversely affect a person’s fertility. The high prevalence of poor diets and increasing obesity, smoking, diabetes, stress, cardiovascular disorders, hypertension, and heart attack can affect a person’s fertility. Moreover, other health conditions such as polycystic ovarian syndrome (PCOS), high alpha-amylase levels among women, and low testosterone levels in men can also cause infertility. All these factors have exploded the demand for infertility drugs in the past few years. Specifically, the alarming increment in the diabetic population has been a leading cause of infertility. These factors are contributing to the growth of the global infertility drugs market.

Increasing Cases of Infertility Among Women to Sustain Momentum of Infertility Drugs Market


Of late, the increasing rate of infertility among women has been a major cause of concern. Most estimates show a significant decline in female fertility rates across the world in the past few years. The incidence of diseases such as breast cancer and thyroid-related disorders has also grown of late. In such a business environment, the demand for female fertility treatment methods is expected to increase substantially. The number of female infertility treatment methods has increased of late and many women are being educated to watch out for their reproductive health. The global infertility drugs market is expected to expand owing to these factors.

North America to Lead Infertility Drugs Market Amidst Growing Fertility Complications


The region of North America has showcased an incessant rise in cases of urinary infections, menopausal disorders, endometriosis, and thyroid complications, among others. Besides, hectic lifestyles and stress are becoming more common in the region, especially among women. In men, diseases such as diabetes, varicocele, and oligozoospermia are increasing at a fast pace. All these factors, coupled with the presence of a robust healthcare infrastructure, high healthcare expenditure, and concentration of several market entities are establishing North America as the leading regional infertility drugs market.

Leading Market Players


The most active players in the global infertility drugs market include Bayer AG, Pfizer Inc., Abbott Laboratories, Livzon Pharmaceutical Group Inc., Ferring Pharmaceuticals, Merck Co. Inc., Mankind Pharma, Novartis AG, Merck KGaA, Sanofi S.A., and Thermax.


Get a Sample Copy/TOC of Infertility Drugs Market :



  • Latest Trending Report :







About us


Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published updated to ensure the ever-changing needs of customers are met with absolute promptness.




Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746



Follow Us: LinkedIn